The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans.
D000085:Acetates; D000818:Animals; D001059:Apoproteins; D001798:Blood Proteins / Q000032:analysis; D055598:Chemical Phenomena; D002621:Chemistry; D002807:Chondroitin; D002846:Chromatography, Affinity; D002850:Chromatography, Gel; D003488:Cyanogen Bromide; D004586:Electrophoresis; D005782:Gels; D006025:Glycosaminoglycans; D006493:Heparin; D006801:Humans; D006820:Hyaluronic Acid; D005779:Immunodiffusion; D008055:Lipids / Q000032:analysis; D008074:Lipoproteins / Q000032:analysis / Q000097:blood; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009994:Osmolar Concentration; D011134:Polysaccharides; D011485:Protein Binding; D011817:Rabbits / Q000276:immunology; D013464:Sulfuric Acids; D014574:Uronic Acids
D000085:Acetates; D001059:Apoproteins; D001798:Blood Proteins; D005782:Gels; D006025:Glycosaminoglycans; D008055:Lipids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D011134:Polysaccharides; D013464:Sulfuric Acids; D014574:Uronic Acids; D006820:Hyaluronic Acid; D006493:Heparin; D002807:Chondroitin; D003488:Cyanogen Bromide